These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

264 related articles for article (PubMed ID: 21414759)

  • 1. Extracellular and intracellular bactericidal activities of XF-70 against small-colony variant hemB mutants of meticillin-susceptible and meticillin-resistant Staphylococcus aureus.
    Vaudaux P; Huggler E; Rhys-Williams W; Love WG; Lew DP
    Int J Antimicrob Agents; 2011 Jun; 37(6):576-9. PubMed ID: 21414759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Daptomycin pharmacodynamics against Staphylococcus aureus hemB mutants displaying the small colony variant phenotype.
    Begic D; von Eiff C; Tsuji BT
    J Antimicrob Chemother; 2009 May; 63(5):977-81. PubMed ID: 19304733
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of XF-73, a novel antibacterial agent, against antibiotic-sensitive and -resistant Gram-positive and Gram-negative bacterial species.
    Farrell DJ; Robbins M; Rhys-Williams W; Love WG
    Int J Antimicrob Agents; 2010 Jun; 35(6):531-6. PubMed ID: 20346634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intracellular activity of the peptide antibiotic NZ2114: studies with Staphylococcus aureus and human THP-1 monocytes, and comparison with daptomycin and vancomycin.
    Brinch KS; Tulkens PM; Van Bambeke F; Frimodt-Møller N; Høiby N; Kristensen HH
    J Antimicrob Chemother; 2010 Aug; 65(8):1720-4. PubMed ID: 20534628
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.
    Dalhoff A; Schubert S
    Int J Antimicrob Agents; 2010 Sep; 36(3):216-21. PubMed ID: 20630710
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intracellular forms of menadione-dependent small-colony variants of methicillin-resistant Staphylococcus aureus are hypersusceptible to β-lactams in a THP-1 cell model due to cooperation between vacuolar acidic pH and oxidant species.
    Garcia LG; Lemaire S; Kahl BC; Becker K; Proctor RA; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2012 Dec; 67(12):2873-81. PubMed ID: 23002174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. XF-73, a novel antistaphylococcal membrane-active agent with rapid bactericidal activity.
    Ooi N; Miller K; Hobbs J; Rhys-Williams W; Love W; Chopra I
    J Antimicrob Chemother; 2009 Oct; 64(4):735-40. PubMed ID: 19689976
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of the extracellular and intracellular activities (human THP-1 macrophages) of telavancin versus vancomycin against methicillin-susceptible, methicillin-resistant, vancomycin-intermediate and vancomycin-resistant Staphylococcus aureus.
    Barcia-Macay M; Lemaire S; Mingeot-Leclercq MP; Tulkens PM; Van Bambeke F
    J Antimicrob Chemother; 2006 Dec; 58(6):1177-84. PubMed ID: 17062609
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Activity of quinupristin/dalfopristin against extracellular and intracellular Staphylococcus aureus with various resistance phenotypes.
    Baudoux P; Lemaire S; Denis O; Tulkens PM; Van Bambeke F; Glupczynski Y
    J Antimicrob Chemother; 2010 Jun; 65(6):1228-36. PubMed ID: 20378672
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative in vitro activity of telavancin, vancomycin and linezolid against heterogeneously vancomycin-intermediate Staphylococcus aureus (hVISA).
    Leonard SN; Szeto YG; Zolotarev M; Grigoryan IV
    Int J Antimicrob Agents; 2011 Jun; 37(6):558-61. PubMed ID: 21497067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Bactericidal activity of daptomycin versus vancomycin in the presence of human albumin against vancomycin-susceptible but tolerant methicillin-resistant Staphylococcus aureus (MRSA) with daptomycin minimum inhibitory concentrations of 1-2microg/mL.
    Torrico M; Giménez MJ; González N; Alou L; Sevillano D; Cafini F; Prieto J; Cleeland R; Aguilar L
    Int J Antimicrob Agents; 2010 Feb; 35(2):131-7. PubMed ID: 20006469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro pharmacodynamics of novel rifamycin ABI-0043 against Staphylococcus aureus.
    Tsuji BT; Yang JC; Forrest A; Kelchlin PA; Smith PF
    J Antimicrob Chemother; 2008 Jul; 62(1):156-60. PubMed ID: 18400804
    [TBL] [Abstract][Full Text] [Related]  

  • 13. XF-70 and XF-73, novel antibacterial agents active against slow-growing and non-dividing cultures of Staphylococcus aureus including biofilms.
    Ooi N; Miller K; Randall C; Rhys-Williams W; Love W; Chopra I
    J Antimicrob Chemother; 2010 Jan; 65(1):72-8. PubMed ID: 19889790
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small colony variants of Staphylococcus aureus reveal distinct protein profiles.
    Kriegeskorte A; König S; Sander G; Pirkl A; Mahabir E; Proctor RA; von Eiff C; Peters G; Becker K
    Proteomics; 2011 Jun; 11(12):2476-90. PubMed ID: 21595038
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro effect of the presence of human albumin or human serum on the bactericidal activity of daptomycin against strains with the main resistance phenotypes in Gram-positives.
    Cafini F; Aguilar L; González N; Giménez MJ; Torrico M; Alou L; Sevillano D; Vallejo P; Prieto J
    J Antimicrob Chemother; 2007 Jun; 59(6):1185-9. PubMed ID: 17412725
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activity of oritavancin and comparators in vitro against standard and high inocula of Staphylococcus aureus.
    Arhin FF; Sarmiento I; Parr TR; Moeck G
    Int J Antimicrob Agents; 2012 Feb; 39(2):159-62. PubMed ID: 22070858
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistence of a Staphylococcus aureus small-colony variant under antibiotic pressure in vivo.
    Brouillette E; Martinez A; Boyll BJ; Allen NE; Malouin F
    FEMS Immunol Med Microbiol; 2004 May; 41(1):35-41. PubMed ID: 15094165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative in vitro activity of finafloxacin against staphylococci displaying normal and small colony variant phenotypes.
    Idelevich EA; Kriegeskorte A; Stubbings W; Kahl BC; Peters G; Becker K
    J Antimicrob Chemother; 2011 Dec; 66(12):2809-13. PubMed ID: 21948963
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A novel bactericidal fabric coating with potent in vitro activity against meticillin-resistant Staphylococcus aureus (MRSA).
    O'Hanlon SJ; Enright MC
    Int J Antimicrob Agents; 2009 May; 33(5):427-31. PubMed ID: 19112009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a Staphylococcus aureus small colony variant (SCV) associated with persistent bovine mastitis.
    Atalla H; Gyles C; Jacob CL; Moisan H; Malouin F; Mallard B
    Foodborne Pathog Dis; 2008 Dec; 5(6):785-99. PubMed ID: 19014276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.